Nifty
:
25722.10
Sensex
:
83938.71
-155.75 (-0.60%)
-465.75 (-0.55%)
Nifty
Sensex
:
:
25722.10
83938.71
-155.75 (-0.60%)
-465.75 (-0.55%)

3B Blackbio Dx Ltd.

Pesticides & Agrochemicals

Rating :
59/99

BSE: 532067 | NSE: Not Listed

NSE BSE
1377.85
31-Oct-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1345
  •  1387.5
  •  1340.2
  •  1345.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  4508
  •  6188562
  •  1387.5
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,182.56
  • 24.12
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,114.04
  • 0.29%
  • 4.21

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 41.28%
  • 5.22%
  • 43.53%
  • FII
  • DII
  • Others
  • 2.64%
  • 0.00%
  • 7.33%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.73
  • -15.71
  • 15.98

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 41.94
  • -19.69
  • 11.47

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 59.77
  • -15.98
  • 22.50

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.71
  • 14.78
  • 24.06

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.93
  • 3.75
  • 3.95

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.40
  • 11.02
  • 15.80

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
22.23
19.43
14.41%
22.49
23.00
-2.22%
25.39
17.67
43.69%
29.15
19.18
51.98%
Expenses
10.40
8.49
22.50%
14.57
13.12
11.05%
10.32
8.79
17.41%
12.97
11.39
13.87%
EBITDA
11.83
10.94
8.14%
7.92
9.88
-19.84%
15.07
8.88
69.71%
16.18
7.79
107.70%
EBIDTM
53.22%
56.29%
35.21%
42.96%
59.36%
50.23%
55.50%
40.60%
Other Income
4.32
3.69
17.07%
4.94
4.19
17.90%
3.01
2.63
14.45%
3.44
2.75
25.09%
Interest
0.01
0.01
0.00%
0.04
0.04
0.00%
0.02
0.03
-33.33%
0.03
0.04
-25.00%
Depreciation
0.28
0.27
3.70%
0.28
0.30
-6.67%
0.27
0.32
-15.62%
0.27
0.24
12.50%
PBT
15.86
14.36
10.45%
12.54
13.73
-8.67%
17.80
11.15
59.64%
19.31
10.26
88.21%
Tax
3.22
3.06
5.23%
4.50
4.94
-8.91%
4.30
2.64
62.88%
4.44
2.67
66.29%
PAT
12.64
11.30
11.86%
8.04
8.79
-8.53%
13.49
8.52
58.33%
14.86
7.59
95.78%
PATM
56.87%
58.13%
35.72%
38.22%
53.15%
48.21%
50.99%
39.57%
EPS
14.69
12.99
13.09%
9.80
10.35
-5.31%
15.64
10.18
53.63%
17.10
9.17
86.48%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
99.26
96.47
74.12
61.84
80.65
226.74
28.87
23.28
23.21
16.16
17.33
Net Sales Growth
25.20%
30.15%
19.86%
-23.32%
-64.43%
685.38%
24.01%
0.30%
43.63%
-6.75%
 
Cost Of Goods Sold
26.53
25.65
21.84
17.91
31.62
51.57
13.26
10.83
12.50
0.11
10.28
Gross Profit
72.73
70.82
52.28
43.92
49.03
175.17
15.61
12.45
10.71
16.05
7.05
GP Margin
73.27%
73.41%
70.53%
71.02%
60.79%
77.26%
54.07%
53.48%
46.14%
99.32%
40.68%
Total Expenditure
48.26
46.36
41.14
32.73
43.55
76.75
19.56
16.06
17.79
13.60
15.82
Power & Fuel Cost
-
0.20
0.22
0.24
0.23
0.24
0.20
0.18
0.20
0.19
0.16
% Of Sales
-
0.21%
0.30%
0.39%
0.29%
0.11%
0.69%
0.77%
0.86%
1.18%
0.92%
Employee Cost
-
3.55
4.28
3.58
2.23
0.55
2.85
2.53
2.11
1.74
1.92
% Of Sales
-
3.68%
5.77%
5.79%
2.77%
0.24%
9.87%
10.87%
9.09%
10.77%
11.08%
Manufacturing Exp.
-
0.93
1.00
1.18
0.57
0.57
0.07
0.06
0.33
8.56
0.09
% Of Sales
-
0.96%
1.35%
1.91%
0.71%
0.25%
0.24%
0.26%
1.42%
52.97%
0.52%
General & Admin Exp.
-
7.56
3.85
3.38
3.11
8.14
0.79
0.73
0.73
0.70
0.48
% Of Sales
-
7.84%
5.19%
5.47%
3.86%
3.59%
2.74%
3.14%
3.15%
4.33%
2.77%
Selling & Distn. Exp.
-
1.38
1.92
1.82
1.72
1.64
0.93
0.53
0.67
0.68
0.94
% Of Sales
-
1.43%
2.59%
2.94%
2.13%
0.72%
3.22%
2.28%
2.89%
4.21%
5.42%
Miscellaneous Exp.
-
7.09
8.04
4.61
4.05
14.05
1.45
1.19
1.24
1.62
0.94
% Of Sales
-
7.35%
10.85%
7.45%
5.02%
6.20%
5.02%
5.11%
5.34%
10.02%
11.25%
EBITDA
51.00
50.11
32.98
29.11
37.10
149.99
9.31
7.22
5.42
2.56
1.51
EBITDA Margin
51.38%
51.94%
44.50%
47.07%
46.00%
66.15%
32.25%
31.01%
23.35%
15.84%
8.71%
Other Income
15.71
15.08
12.53
7.26
6.90
2.89
1.60
0.74
0.28
0.27
0.12
Interest
0.10
0.11
0.12
0.20
0.11
0.23
0.33
0.46
0.73
0.98
0.78
Depreciation
1.10
1.09
1.06
0.86
0.67
0.62
0.54
0.55
0.46
0.45
0.41
PBT
65.51
64.00
44.33
35.31
43.22
152.04
10.05
6.95
4.52
1.40
0.44
Tax
16.46
16.31
12.23
9.37
11.02
38.17
2.36
1.71
1.09
0.27
0.10
Tax Rate
25.13%
25.48%
27.59%
26.54%
25.50%
25.11%
23.46%
24.60%
24.12%
19.29%
22.73%
PAT
49.03
47.69
32.10
25.94
32.20
113.87
7.69
5.24
3.43
1.13
0.44
PAT before Minority Interest
49.02
47.69
32.10
25.94
32.20
113.87
7.69
5.24
3.43
1.13
0.33
Minority Interest
-0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.11
PAT Margin
49.40%
49.44%
43.31%
41.95%
39.93%
50.22%
26.64%
22.51%
14.78%
6.99%
2.54%
PAT Growth
35.44%
48.57%
23.75%
-19.44%
-71.72%
1,380.75%
46.76%
52.77%
203.54%
156.82%
 
EPS
57.01
55.45
37.33
30.16
37.44
132.41
8.94
6.09
3.99
1.31
0.51

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
268.42
223.05
193.26
153.02
132.05
32.11
22.50
18.38
11.21
10.42
Share Capital
8.57
8.57
8.57
7.49
7.49
7.49
6.39
6.38
6.38
6.38
Total Reserves
259.85
214.48
184.69
145.53
124.56
24.62
16.11
7.28
4.83
4.04
Non-Current Liabilities
6.13
5.10
3.96
3.11
2.28
2.42
3.14
3.18
3.62
3.34
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.08
0.11
0.15
0.87
0.00
Unsecured Loans
0.31
0.79
0.91
0.84
1.02
1.39
2.03
2.15
2.07
2.67
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
18.59
17.53
14.18
16.90
42.96
8.16
10.44
8.69
10.78
10.40
Trade Payables
1.97
3.95
3.37
3.54
2.95
3.39
3.91
3.48
4.28
4.67
Other Current Liabilities
1.80
2.69
1.22
1.70
1.25
0.35
0.20
0.23
0.26
0.58
Short Term Borrowings
0.00
0.06
1.12
1.69
0.99
2.06
4.05
3.49
5.75
5.07
Short Term Provisions
14.82
10.83
8.48
9.97
37.78
2.36
2.27
1.48
0.49
0.09
Total Liabilities
295.72
248.10
214.05
192.08
193.51
44.83
36.33
30.40
25.65
24.08
Net Block
7.22
7.40
7.79
6.61
5.00
3.87
3.97
3.75
3.28
3.35
Gross Block
15.01
14.11
14.08
11.99
10.51
8.76
8.32
7.55
3.53
6.30
Accumulated Depreciation
7.79
6.71
6.29
5.38
5.51
4.89
4.35
3.81
0.25
2.95
Non Current Assets
163.53
124.71
99.82
110.55
75.14
5.50
4.21
4.06
3.50
3.54
Capital Work in Progress
0.00
0.00
0.09
0.11
0.13
0.20
0.10
0.15
0.05
0.12
Non Current Investment
156.31
117.31
91.71
92.64
58.81
1.20
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
0.00
0.00
0.23
0.28
0.28
0.23
0.14
0.16
0.17
0.07
Other Non Current Assets
0.00
0.00
0.00
10.91
10.91
0.00
0.00
0.00
0.00
0.00
Current Assets
132.19
123.39
114.24
81.54
118.38
39.33
32.13
26.34
22.15
20.55
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
8.74
8.43
8.04
7.43
4.87
4.07
4.99
3.67
4.01
3.28
Sundry Debtors
36.52
36.25
33.94
29.98
34.79
19.93
18.48
16.48
14.23
13.44
Cash & Bank
68.83
62.15
59.21
28.89
35.08
9.38
3.37
1.58
0.43
0.43
Other Current Assets
18.09
0.00
0.09
3.79
43.64
5.95
5.27
4.60
3.48
3.40
Short Term Loans & Adv.
18.09
16.57
12.96
11.45
38.98
1.87
1.39
4.60
3.48
3.40
Net Current Assets
113.60
105.86
100.05
64.64
75.42
31.18
21.69
17.65
11.37
10.14
Total Assets
295.72
248.10
214.06
192.09
193.52
44.83
36.34
30.40
25.65
24.09

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
43.36
26.95
20.28
37.33
97.52
7.04
3.57
1.94
0.67
0.94
PBT
64.00
44.33
35.31
43.22
152.04
10.05
6.95
4.52
1.40
0.44
Adjustment
-4.86
-4.95
-1.56
0.78
0.84
0.88
1.01
1.19
1.44
1.19
Changes in Working Capital
-0.99
-1.59
-4.52
3.89
-17.47
-1.47
-2.81
-2.87
-1.91
-0.59
Cash after chg. in Working capital
58.14
37.79
29.23
47.89
135.41
9.45
5.16
2.83
0.93
1.03
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-14.78
-10.84
-8.94
-10.56
-37.89
-2.41
-1.59
-0.89
-0.26
-0.09
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-33.85
-20.32
14.73
-28.44
-70.26
-0.64
-0.69
-1.02
-0.41
-0.02
Net Fixed Assets
-0.70
-5.27
-0.06
-1.52
-0.14
-0.11
-0.11
-0.11
-0.15
-0.23
Net Investments
-39.00
-124.10
0.00
0.00
0.00
-2.25
0.00
-0.75
-0.43
0.00
Others
5.85
109.05
14.79
-26.92
-70.12
1.72
-0.58
-0.16
0.17
0.21
Cash from Financing Activity
-3.22
-3.63
-5.01
-15.07
-1.57
0.81
-1.09
0.24
-0.26
-0.85
Net Cash Inflow / Outflow
6.29
3.01
30.01
-6.19
25.70
7.21
1.79
1.16
0.00
0.07
Opening Cash & Equivalents
62.15
59.21
28.89
35.08
9.38
2.17
0.38
0.43
0.43
0.35
Closing Cash & Equivalent
68.83
62.15
59.21
28.89
35.08
9.38
2.17
1.58
0.43
0.43

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
313.27
260.32
225.60
204.26
176.27
42.87
35.20
21.40
17.57
16.33
ROA
17.54%
13.89%
12.77%
16.70%
95.54%
18.94%
15.71%
12.22%
4.55%
1.37%
ROE
19.41%
15.42%
14.98%
22.59%
138.73%
28.15%
28.99%
27.55%
10.47%
3.26%
ROCE
26.03%
21.21%
20.24%
29.92%
179.46%
32.29%
28.04%
23.80%
12.52%
6.80%
Fixed Asset Turnover
6.63
5.26
4.74
7.17
23.54
3.38
2.93
4.23
3.54
3.03
Receivable days
137.66
172.80
188.65
146.56
44.04
242.80
274.14
239.28
290.63
261.70
Inventory Days
32.48
40.55
45.68
27.85
7.20
57.29
67.94
59.84
76.56
70.01
Payable days
42.09
61.16
70.42
37.45
22.43
74.03
89.04
85.72
132.91
141.09
Cash Conversion Cycle
128.05
152.20
163.91
136.97
28.82
226.06
253.03
213.39
234.28
190.62
Total Debt/Equity
0.00
0.00
0.01
0.02
0.02
0.11
0.28
0.42
0.78
0.74
Interest Cover
590.84
357.08
178.97
407.23
666.83
31.08
16.02
7.19
2.42
1.56

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • 3B Blackbio Dx - Quarterly Results
    14th Aug 2025, 15:52 PM

    Read More
  • 3B Blackbio Dx inks pact to acquire stake in Coris Holding SRL
    28th Jul 2025, 15:41 PM

    Coris Bioconcept SRL shall become a subsidiary of the company

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.